Latest News and Press Releases

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) indberetter hermed følgende transaktioner: 1.Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til dennea)NavnBertil...

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions: 1.Details of the person discharging managerial responsibility / person closely associateda)NameBertil Lindmark2.Reason...

Bemærk venligst, at rapporten udelukkende findes på engelsk ALK reports revenue up 13% with sales growth across its portfolio, outlook updated (unaudited) ALK’s revenue growth increased during Q2 on...

ALK reports revenue up 13% with sales growth across its portfolio, outlook updated (unaudited) ALK’s revenue growth increased during Q2 on continued strong momentum for tablet sales and a recovery in...

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) meddeler i dag, at selskabet opjusterer forventningerne til regnskabsåret 2021, især til stigende indtjening, for at afspejle et bedre salgsforecast samt...

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the company is upgrading its full-year financial outlook especially with regards to increasing earnings to reflect an improved sales...

Bestyrelsen for ALK-Abelló A/S (ALKB:DC / OMX: ALK B / AKABY / AKBLF) meddeler i dag, at den vil indstille Alan Main, tidligere direktør for Consumer Healthcare i Sanofi, som uafhængigt medlem af...

The Board of Directors of ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) is to nominate the former head of Consumer Healthcare at Sanofi, Alan Main, as an independent member of the Board of ALK-Abelló...

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) offentliggør delårsrapport for første halvår (Q2) 2021 onsdag den 11. august 2021. ALK afholder samme dag kl. 13.30 (CEST) en telefonkonference for...

On Wednesday, 11 August 2021, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its six-month interim report (Q2) 2021. ALK will host a meeting for analysts and institutional investors that day at...